• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TIM3/CEACAM1通路参与骨髓增生异常综合征中髓系来源抑制细胞诱导的CD8 T细胞耗竭及骨髓炎性微环境。

TIM3/CEACAM1 pathway involves in myeloid-derived suppressor cells induced CD8 T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome.

作者信息

Yu Shunjie, Ren Xiaotong, Meng Fanqiao, Guo Xinyu, Tao Jinglian, Zhang Wei, Liu Zhaoyun, Fu Rong, Li Lijuan

机构信息

Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China. Address:Heping District 154 Anshan Road, Tianjin, China.

出版信息

Immunology. 2023 Feb;168(2):273-289. doi: 10.1111/imm.13488. Epub 2022 May 3.

DOI:10.1111/imm.13488
PMID:35470423
Abstract

Myeloid-derived suppressor cells (MDSC) induced cellular immune deficiency and bone marrow inflammatory microenvironment play an important role in the pathogenesis and progression of myelodysplastic syndrome (MDS), but the underlying mechanism remains unclear. Here, we revealed that immune checkpoint protein TIM3 and CEACAM1 were highly demonstrated on MDSC and CD8 T cells in MDS patients. CD8 T cells were reduced in number and function and presented a exhaustion state. The levels of pro-inflammatory cytokines (IL-1β, IL-18) and CEACAM1 were raised in bone marrow supernatants and MDSC culture supernatants. Blocking or neutralizing TIM3/CEACAM1 and IL-1β/IL-18 partially reversed exhaustion of CD8 T cells. Moreover, TIM3 correlated with NF-κB /NLRP3 inflammatory pathway. The levels of NF-κB/NLRP3/Caspase-1/IL-1β and IL-18 were all increased in MDSC of MDS. Co-culturing MDSC from MDS patients with rhCEACAM1 enhanced NF-κB/NLRP3/Caspase-1/IL-1β and IL-18 levels, whereas blocking TIM3 could partially reverse the above manifestations. These results indicated that TIM3/CEACAM1 pathway involved in CD8 T cells exhaustion and might activate the NF-κB/NLRP3/Caspase-1 pathway in MDSC, increasing pro-inflammatory cytokines secretion in MDS bone marrow microenvironment. This study provided a basis for applying immune checkpoint inhibitors that could simultaneously modulate pro-inflammatory cytokine secretion and enhance anti-tumour immune function in the treatment of MDS.

摘要

髓系来源的抑制性细胞(MDSC)诱导的细胞免疫缺陷和骨髓炎性微环境在骨髓增生异常综合征(MDS)的发病机制和进展中起重要作用,但其潜在机制仍不清楚。在此,我们发现免疫检查点蛋白TIM3和CEACAM1在MDS患者的MDSC和CD8 T细胞上高度表达。CD8 T细胞数量减少且功能受损,并呈现耗竭状态。骨髓上清液和MDSC培养上清液中促炎细胞因子(IL-1β、IL-18)和CEACAM1水平升高。阻断或中和TIM3/CEACAM1以及IL-1β/IL-18可部分逆转CD8 T细胞的耗竭。此外,TIM3与NF-κB/NLRP3炎性途径相关。MDS患者的MDSC中NF-κB/NLRP3/Caspase-1/IL-1β和IL-18水平均升高。将MDS患者的MDSC与重组CEACAM1共培养可提高NF-κB/NLRP3/Caspase-1/IL-1β和IL-18水平,而阻断TIM3可部分逆转上述表现。这些结果表明,TIM3/CEACAM1途径参与CD8 T细胞耗竭,并可能激活MDSC中的NF-κB/NLRP3/Caspase-1途径,增加MDS骨髓微环境中促炎细胞因子的分泌。本研究为应用可同时调节促炎细胞因子分泌并增强抗肿瘤免疫功能的免疫检查点抑制剂治疗MDS提供了依据。

相似文献

1
TIM3/CEACAM1 pathway involves in myeloid-derived suppressor cells induced CD8 T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome.TIM3/CEACAM1通路参与骨髓增生异常综合征中髓系来源抑制细胞诱导的CD8 T细胞耗竭及骨髓炎性微环境。
Immunology. 2023 Feb;168(2):273-289. doi: 10.1111/imm.13488. Epub 2022 May 3.
2
CD8 T cells exhaustion induced by myeloid-derived suppressor cells in myelodysplastic syndromes patients might be through TIM3/Gal-9 pathway.髓系来源抑制细胞诱导骨髓增生异常综合征患者 CD8 T 细胞耗竭可能通过 TIM3/Gal-9 通路。
J Cell Mol Med. 2020 Jan;24(1):1046-1058. doi: 10.1111/jcmm.14825. Epub 2019 Nov 22.
3
Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.富氢盐水通过抑制炎症反应减轻大鼠蛛网膜下腔出血诱导的早期脑损伤:NF-κB通路和NLRP3炎性小体的可能参与
Mol Neurobiol. 2016 Jul;53(5):3462-3476. doi: 10.1007/s12035-015-9242-y. Epub 2015 Jun 20.
4
Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.微藻三角褐指藻中的岩藻黄质通过调控 NF-κB 和 NLRP3 炎性小体的激活来抑制促炎细胞因子。
Sci Rep. 2021 Jan 12;11(1):543. doi: 10.1038/s41598-020-80748-6.
5
Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways.缺失pyrin 样蛋白 M013 的粘液瘤病毒可被人髓系细胞中的 NLRP3 和多种 Toll 样受体识别,这些受体可独立激活炎症小体和 NF-κB 先天反应途径。
J Virol. 2011 Dec;85(23):12505-17. doi: 10.1128/JVI.00410-11. Epub 2011 Sep 28.
6
Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation.S100A9通过NLRP3炎性小体激活诱导间充质基质细胞发生细胞衰老。
Aging (Albany NY). 2019 Nov 14;11(21):9626-9642. doi: 10.18632/aging.102409.
7
Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.MCC950 阻断 NLRP3 炎性小体可改善头颈部鳞状细胞癌的抗肿瘤免疫反应。
Cell Mol Life Sci. 2018 Jun;75(11):2045-2058. doi: 10.1007/s00018-017-2720-9. Epub 2017 Nov 28.
8
HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.HBV 通过抑制 NF-κB 通路和 ROS 产生来抑制 LPS 诱导的 NLRP3 炎性小体激活和 IL-1β 产生。
J Hepatol. 2017 Apr;66(4):693-702. doi: 10.1016/j.jhep.2016.12.018. Epub 2016 Dec 24.
9
Anti-Inflammation and Anti-Pyroptosis Activities of Mangiferin via Suppressing NF-κB/NLRP3/GSDMD Signaling Cascades.山竹堿通过抑制 NF-κB/NLRP3/GSDMD 信号级联发挥抗炎和抗焦亡作用。
Int J Mol Sci. 2022 Sep 4;23(17):10124. doi: 10.3390/ijms231710124.
10
Effect of Berberine on Activation of TLR4-NFκB Signaling Pathway and NLRP3 Inflammasome in Patients with Gout.黄连素对痛风患者TLR4-NFκB信号通路及NLRP3炎性小体激活的影响
Chin J Integr Med. 2023 Jan;29(1):10-18. doi: 10.1007/s11655-022-3720-7. Epub 2022 Sep 20.

引用本文的文献

1
Advances in the study of TIM3 in myelodysplastic syndrome.骨髓增生异常综合征中TIM3的研究进展
Front Immunol. 2025 Aug 19;16:1647401. doi: 10.3389/fimmu.2025.1647401. eCollection 2025.
2
First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors.抗TIM-3单克隆抗体INCAGN02390用于特定晚期或转移性实体瘤患者的首次人体I期开放标签研究。
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf144.
3
Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic Prospects.
骨髓增生异常肿瘤(MDS):发病机制与治疗前景
Biomolecules. 2025 May 25;15(6):761. doi: 10.3390/biom15060761.
4
Bone marrow microenvironment in myelodysplastic neoplasms: insights into pathogenesis, biomarkers, and therapeutic targets.骨髓增生异常综合征中的骨髓微环境:对发病机制、生物标志物及治疗靶点的见解
Cancer Cell Int. 2025 May 10;25(1):175. doi: 10.1186/s12935-025-03793-z.
5
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception.人类和小鼠肺腺癌前体的空间和多组学分析揭示TIM-3是癌前病变拦截的潜在靶点。
Cancer Cell. 2025 Jun 9;43(6):1125-1140.e10. doi: 10.1016/j.ccell.2025.04.003. Epub 2025 May 8.
6
TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives.TIM-3与PD-1在癌症免疫治疗中的协同作用:机制与展望。
Mol Biomed. 2025 May 7;6(1):27. doi: 10.1186/s43556-025-00267-6.
7
Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis.T细胞免疫球蛋白和粘蛋白结构域包含分子3在上消化道肿瘤中的表达的预后价值:一项荟萃分析。
World J Gastrointest Oncol. 2023 Dec 15;15(12):2212-2224. doi: 10.4251/wjgo.v15.i12.2212.
8
Killer instincts: natural killer cells as multifactorial cancer immunotherapy.杀手本能:自然杀伤细胞作为多因素癌症免疫疗法。
Front Immunol. 2023 Nov 28;14:1269614. doi: 10.3389/fimmu.2023.1269614. eCollection 2023.
9
The role of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer.癌胚抗原相关细胞黏附分子 1 在癌症中的作用。
Front Immunol. 2023 Nov 24;14:1295232. doi: 10.3389/fimmu.2023.1295232. eCollection 2023.
10
The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant.动员外周血造血干细胞的免疫组学可预测多发性骨髓瘤患者自体造血干细胞移植后长期结局和治疗相关髓系肿瘤。
Blood Cancer J. 2023 Sep 26;13(1):151. doi: 10.1038/s41408-023-00920-9.